GB201105979D0 - Novel estrogen receptor ligands - Google Patents
Novel estrogen receptor ligandsInfo
- Publication number
- GB201105979D0 GB201105979D0 GBGB1105979.7A GB201105979A GB201105979D0 GB 201105979 D0 GB201105979 D0 GB 201105979D0 GB 201105979 A GB201105979 A GB 201105979A GB 201105979 D0 GB201105979 D0 GB 201105979D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- estrogen receptor
- receptor ligands
- novel estrogen
- novel
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000015694 estrogen receptors Human genes 0.000 title 1
- 108010038795 estrogen receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1105979.7A GB201105979D0 (en) | 2011-04-07 | 2011-04-07 | Novel estrogen receptor ligands |
| PCT/EP2012/056293 WO2012136772A1 (en) | 2011-04-07 | 2012-04-05 | Fused pyrrole derivates as estrogen receptor ligands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1105979.7A GB201105979D0 (en) | 2011-04-07 | 2011-04-07 | Novel estrogen receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201105979D0 true GB201105979D0 (en) | 2011-05-18 |
Family
ID=44072172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1105979.7A Ceased GB201105979D0 (en) | 2011-04-07 | 2011-04-07 | Novel estrogen receptor ligands |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201105979D0 (en) |
| WO (1) | WO2012136772A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201113538D0 (en) | 2011-08-04 | 2011-09-21 | Karobio Ab | Novel estrogen receptor ligands |
| EP3189026B1 (en) | 2014-09-02 | 2020-07-22 | The Regents of The University of California | Estrogen receptor ligand treatment for neurodegenerative diseases |
| CN106278993B (en) * | 2015-05-15 | 2019-05-21 | 兰州大学 | A kind of synthetic method of the polysubstituted pyrrole of gold catalysis |
| CN107496419B (en) * | 2016-06-14 | 2021-03-23 | 兰州大学 | Cyclopenta [ b ] pyrrole compound with anti-inflammatory activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030220377A1 (en) | 2002-05-08 | 2003-11-27 | Richard Chesworth | Indole compounds and their use as estrogen agonists/antagonists |
| US7250440B2 (en) | 2003-08-12 | 2007-07-31 | Wyeth | (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents |
| EP1889617A1 (en) | 2006-07-11 | 2008-02-20 | Freie Universität Berlin | Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents |
| HUE025471T2 (en) * | 2008-04-16 | 2016-03-29 | Karobio Ab | Novel estrogen receptor ligands |
-
2011
- 2011-04-07 GB GBGB1105979.7A patent/GB201105979D0/en not_active Ceased
-
2012
- 2012-04-05 WO PCT/EP2012/056293 patent/WO2012136772A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012136772A1 (en) | 2012-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201103955D0 (en) | Antibodies | |
| GB201112056D0 (en) | Antibodies | |
| GB0917571D0 (en) | Novel estrogen receptor ligands | |
| SG2014012280A (en) | Bracket | |
| IL239080A0 (en) | Neurotensin receptor ligands | |
| PL2760315T3 (en) | Bracket | |
| GB201110973D0 (en) | Bracket | |
| IL231518A0 (en) | Ep1 receptor ligands | |
| AU337816S (en) | Bracket | |
| ZA201400708B (en) | Novel estrogen receptor ligands | |
| GB201213822D0 (en) | Checkweigher | |
| GB201105979D0 (en) | Novel estrogen receptor ligands | |
| ZA201500220B (en) | Novel cholecystokinin receptor ligands | |
| EP2714074A4 (en) | Anti-emr1 antibodies | |
| HUP1100731A2 (en) | Complex forming compounds | |
| GB2496130B (en) | Bracket | |
| GB201105984D0 (en) | Novel estrogen receptor ligands | |
| GB201105983D0 (en) | Novel estrogen receptor ligands | |
| GB201011859D0 (en) | Novel estrogen receptor ligands | |
| GB201004377D0 (en) | Novel estrogen receptor ligands | |
| GB201013921D0 (en) | Novel estrogen receptor ligands | |
| GB201201224D0 (en) | Screen for a bandscreen | |
| GB0917575D0 (en) | Novel estrogen receptor ligands | |
| GB0917574D0 (en) | Novel estrogen receptor ligands | |
| GB201118046D0 (en) | Interface bracket |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |